Collagen Solutions plc announced that it has entered into a new agreement with Olaregen Therapeutix Inc. ("Olaregen") to manufacture and produce Excellagen®, an advanced FDA 510(k)-cleared wound healing product indicated for the treatment of hard to heal wounds such as diabetic foot ulcers. With these new agreements, Collagen Solutions is now supporting Olaregen's launch of Excellagen® in the first half of 2019.